Catheter Precision Stock Set to Reverse Split on Monday, October 5th (NYSEAMERICAN:VTAK)

Catheter Precision, Inc. (NYSEAMERICAN:VTAK)’s stock is set to reverse split on Monday, October 5th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 4th.

Catheter Precision Stock Up 4.9%

Shares of NYSEAMERICAN:VTAK opened at $0.15 on Thursday. The company has a quick ratio of 0.18, a current ratio of 0.19 and a debt-to-equity ratio of 0.19. Catheter Precision has a 52-week low of $0.13 and a 52-week high of $3.20. The stock’s fifty day simple moving average is $0.22 and its 200-day simple moving average is $0.69. The company has a market capitalization of $2.16 million, a P/E ratio of -0.02 and a beta of -1.03.

Catheter Precision (NYSEAMERICAN:VTAK) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.92) EPS for the quarter, beating analysts’ consensus estimates of ($19.00) by $18.08. The business had revenue of $1.02 million for the quarter, compared to analyst estimates of $2.00 million. Catheter Precision had a negative return on equity of 37.53% and a negative net margin of 656.03%.

Catheter Precision Company Profile

Catheter Precision, Inc is a medical device company focused on developing technologies for electrophysiology procedures used to diagnose and treat cardiac arrhythmias. Its products are designed to support physicians during catheter-based cardiac procedures, particularly those involving ventricular arrhythmias.

The company’s portfolio includes the VIVO system, a noninvasive cardiac mapping platform intended to help physicians identify the origin of ventricular arrhythmias and plan catheter ablation procedures.